Delivery Order SPE2DB22D3011-SPE2DB24FQ3NN

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of Otezla 30 mg tablets. The contract has a firm fixed price ceiling value of $32,578.47 and a completion date of December 12, 2023. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is for the supply of the pharmaceutical product Otezla 30 mg tablet, 60-count, at a ceiling value of $20,831.88. The award date is October 8, 2024, and the ultimate completion date is October 9, 2024. This delivery order is part of a larger IDC with DLA Troop Support Medical valued at up to $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The firm-fixed-price contract has a ceiling value of $60,854.40 and an ultimate completion date of September 6, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $15,397.10 and is a firm fixed price delivery order contract with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Otezla 30 mg tablet, a specialty medication, with a ceiling value of $2,939.22 and a performance period through August 7, 2024. As a delivery order, this award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a potential value of up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,933.39, is for the delivery of Otezla 30 mg tablets. This is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution company. The contract is for the supply of Otezla 30 mg tablets to DLA Troop Support Medical facilities in support of military treatment programs and facilities. The award has a ceiling value of $30,322.24 and a period of performance through April 4, 2024. This delivery order is part of a larger indefinite delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The total ceiling value of the contract is $25,170.57, and it is a Firm Fixed Price contract type. The award was made on September 19, 2024, with a period of performance through September 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTEZLA 30 mg tablets. The contract has a ceiling value of $40,332.44 and an ultimate completion date of September 30, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, with a ceiling value of $15,738.72 and a completion date of July 8, 2025. The contract is a firm fixed-price arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ3NN
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Otezla 30 mg tablets. The contract has a ceiling value of $10,850.39 and an ultimate completion date of August 29, 2024. This award appears to be part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/27/24, 9:36 AM